Literature DB >> 25197348

Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer.

Zhijun Han1, Lei Liu1, Yaxin Liu1, Shanqing Li1.   

Abstract

SIRT6 is a member of the NAD(+)-dependent class III deacetylase sirtuin family. Current studies have revealed that SIRT6 plays important roles in the epigenetic regulation of genes expression and contribute to the proliferation, differentiation and apoptosis of cancer cells. However, the biological function of SIRT6 in lung cancer has not been elucidated. The present study showed that the mRNA and protein levels of SIRT6 were decreased in human non-small cell lung cancer (NSCLC) tissues and cell lines. MTT assay showed that overexpression of SIRT6 could inhibit the proliferation in NSCLC cells. In contrast, SIRT6 knockdown using small interfering RNA promoted NSCLC cells proliferation. On the molecular level, we found that SIRT6 inhibited the expression of Twist1 both at the mRNA and protein levels in NSCLC cells. Taken together, these results demonstrated for the first time that SIRT6 suppressed NSCLC cells proliferation via down-regulation of Twist1 expression and might provide novel therapeutic targets in the treatment of lung cancer.

Entities:  

Keywords:  Lung cancer; SIRT6; Twist1; cell proliferation

Mesh:

Substances:

Year:  2014        PMID: 25197348      PMCID: PMC4152038     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

2.  Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.

Authors:  Chiao-Po Hsu; Shinichi Oka; Dan Shao; Nirmala Hariharan; Junichi Sadoshima
Journal:  Circ Res       Date:  2009-08-06       Impact factor: 17.367

3.  SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells.

Authors:  Michael Van Meter; Zhiyong Mao; Vera Gorbunova; Andrei Seluanov
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

4.  Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice.

Authors:  Cuiying Xiao; Rui-Hong Wang; Tyler J Lahusen; Ogyi Park; Adeline Bertola; Takashi Maruyama; Della Reynolds; Qiang Chen; Xiaoling Xu; Howard A Young; Wan-Jun Chen; Bin Gao; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

5.  Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Authors:  David Jackman; William Pao; Gregory J Riely; Jeffrey A Engelman; Mark G Kris; Pasi A Jänne; Thomas Lynch; Bruce E Johnson; Vincent A Miller
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

Review 6.  Recent progress in the biology and physiology of sirtuins.

Authors:  Toren Finkel; Chu-Xia Deng; Raul Mostoslavsky
Journal:  Nature       Date:  2009-07-30       Impact factor: 49.962

7.  Metastasis-induction and apoptosis-protection by TWIST in gastric cancer cells.

Authors:  Mei-yan Feng; Kuan Wang; Hong-tao Song; Hong-wei Yu; Yu Qin; Qing-tao Shi; Jing-shu Geng
Journal:  Clin Exp Metastasis       Date:  2009-10-06       Impact factor: 5.150

8.  The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses.

Authors:  Inga Bauer; Alessia Grozio; Denise Lasigliè; Giovanna Basile; Laura Sturla; Mirko Magnone; Giovanna Sociali; Debora Soncini; Irene Caffa; Alessandro Poggi; Gabriele Zoppoli; Michele Cea; Georg Feldmann; Raul Mostoslavsky; Alberto Ballestrero; Franco Patrone; Santina Bruzzone; Alessio Nencioni
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

9.  Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters.

Authors:  Junlin Li; Binhua P Zhou
Journal:  BMC Cancer       Date:  2011-02-01       Impact factor: 4.430

10.  Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through downregulating Twist.

Authors:  Meng He; Xiao-Cheng Cao; Gui-Cheng He; Xi-Feng Sheng; Xiao-Hong Ai; You-Hua Wu
Journal:  Oncol Lett       Date:  2014-02-21       Impact factor: 2.967

View more
  24 in total

Review 1.  The sirtuin 6: An overture in skin cancer.

Authors:  Liz M Garcia-Peterson; Glorimar Guzmán-Pérez; Cassandre R Krier; Nihal Ahmad
Journal:  Exp Dermatol       Date:  2019-12-29       Impact factor: 3.960

2.  The role of SIRT6 in tumors.

Authors:  Vanessa Desantis; Aurelia Lamanuzzi; Angelo Vacca
Journal:  Haematologica       Date:  2018-01       Impact factor: 9.941

3.  miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.

Authors:  Libo Ruan; Jun Chen; Litao Ruan; Anjun Tan; Ping Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  A novel Twist1/hsa-miR138-5p/caspase-3 pathway regulates cell proliferation and apoptosis of human multiple myeloma.

Authors:  Wenjiao Qin; Qin Liu; Xiaoping Xu; Aiping Liu; Huating Zhang; Jingwen Gu; Tao Zhang
Journal:  Ann Hematol       Date:  2020-05-09       Impact factor: 3.673

5.  The sirtuin family in cancer.

Authors:  Luis Filipe Costa-Machado; Pablo J Fernandez-Marcos
Journal:  Cell Cycle       Date:  2019-07-25       Impact factor: 4.534

Review 6.  Association of sirtuins (SIRT1-7) with lung and intestinal diseases.

Authors:  Yuhan Chen; Di Zhou; Yuan Feng; Bingxin Li; Yong Cui; Gang Chen; Ning Li
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

7.  Aberrant SIRT6 expression contributes to melanoma growth: Role of the autophagy paradox and IGF-AKT signaling.

Authors:  Liwen Wang; Weinan Guo; Jinyuan Ma; Wei Dai; Lin Liu; Sen Guo; Jiaxi Chen; Huina Wang; Yuqi Yang; Xiuli Yi; Gang Wang; Tianwen Gao; Guannan Zhu; Chunying Li
Journal:  Autophagy       Date:  2017-12-31       Impact factor: 16.016

Review 8.  CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.

Authors:  M Sachdeva; N Sachdeva; M Pal; N Gupta; I A Khan; M Majumdar; A Tiwari
Journal:  Cancer Gene Ther       Date:  2015-10-23       Impact factor: 5.987

Review 9.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

10.  MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer.

Authors:  Jia-Lin Shang; Shao-Bo Ning; Ying-Yi Chen; Tian-Xiang Chen; Jian Zhang
Journal:  Acta Pharmacol Sin       Date:  2020-06-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.